Early diagnosis of dementia is crucial for effective intervention. This study focuses on using biomarkers from cerebrospinal fluid, blood, neuropsychological tests, neuroimaging, and digital speech processing to predict dementia in individuals with MCI. By integrating these data, high-risk individuals can be identified for personalised prevention plans.